| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/06/2006 | CA2580122A1 Clostridial neurotoxins for use in tissue healing |
| 04/05/2006 | EP1642981A1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642591A1 MEDICINAL COMPOSITION CONTAINING NF-kAPPA B DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1642559A2 Use of creatine and/or creatine derivatives in cosmetic or dermatological preparations |
| 04/05/2006 | EP1641789A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 04/05/2006 | EP1641482A1 Method of treatment of systemic injury secondary to burns |
| 04/05/2006 | EP1641476A2 Use of an antioxidant in a dermatological and/or cosmetic composition |
| 04/05/2006 | EP1641472A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 04/05/2006 | EP1641467A1 (20s)-1alpha-hydroxy-2-methylene-19-nor-vitamin d3 and its uses |
| 04/05/2006 | EP1641466A1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 04/05/2006 | EP1641463A1 Compositions in the form of a spray comprising a pharmaceutical agent at least one volatile silicone and a non-volatile oily phase |
| 04/05/2006 | EP1641459A1 Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis |
| 04/05/2006 | EP1641443A1 Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema |
| 04/05/2006 | EP1641433A1 Novel dermatological and/or cosmetologic hydrating and anti-irritation compositions |
| 04/05/2006 | EP1465636A4 Compositions and methods for enhancing corticosteriod delivery |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1409494B1 Stabilized derivatives of ascorbic acid -3- phosphate |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1370544B1 Nitric oxide donors based on metallic centres |
| 04/05/2006 | EP1333805B1 Cosmetic method of treating skin |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP0991660B8 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1248734C Matrix protein compositions for wound healing |
| 04/05/2006 | CN1248724C Hair regenerating formulation and its production method |
| 04/05/2006 | CN1248694C Chinese medicine hair-growing head-membrane paste and its preparation method |
| 04/05/2006 | CN1248687C Emergency protective agent for wound |
| 04/05/2006 | CN1248685C Analgesic/anti-inflammatory patches for topical use |
| 04/05/2006 | CN1248679C Water soluble microflake through air gap and process thereof |
| 04/05/2006 | CN1248677C Pharmaceutical and cosmetic compositions for protection of skin from damages induced by sun radiations |
| 04/05/2006 | CN1248671C Use of 3-position cyclosporin derivatives for hair growth |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022675 Administering angiotensin ii |
| 04/04/2006 | US7022668 improves adhesion of human dermal fibroblasts and promotes the cellular growth of human epidermal keratinocytes; produced by Pseudoalteromonas antartica; for topical or oral administration; veterinary medicine; for treatment of hair, skin, and nails |
| 04/04/2006 | US7022332 Sulfacetamide formulations for treatment of rosacea |
| 04/04/2006 | CA2356544C Pyridotriazines and pyridopyridazines |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006033473A1 Denatured silk and aqueous extract thereof |
| 03/30/2006 | WO2006033433A1 Wound remedy |
| 03/30/2006 | WO2006033355A1 Oral pharmaceutical for dry skin prevention or remedy |
| 03/30/2006 | WO2006032122A1 An antioxidant complex and a cosmetic and pharmaceutical composition comprising said complex |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069130 Novel crystals |
| 03/30/2006 | US20060069120 Novel piperidine derivaties as modulators of chemokine receptor ccr5 |
| 03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/30/2006 | US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069057 Medicaments containing xenogeneic oligo- and/or polyribonucleotides |
| 03/30/2006 | US20060068480 Polypeptides and polypeptide analogues |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067928 Contacting a linear polysaccharide with a disaccharide repeat unit of a uronic acid [ alpha -L-iduronic acid (I) or beta -D-glucuronic acid] linked 1, 4 to alpha -D-hexosamine with a modified heparinase III in vitro |
| 03/30/2006 | US20060067921 Probiotic bacterium: lactobacillus fermentum |
| 03/30/2006 | US20060067894 Film foaming hydroalcoholic foam |
| 03/30/2006 | CA2581388A1 An antioxidant composition and a cosmetic and pharmaceutical compositioncomprising said antioxidant composition |
| 03/30/2006 | CA2580757A1 Orally administered agent for preventing or improving dry state of skin |
| 03/30/2006 | CA2578121A1 Use of metronidazole combined with azelaic acid for the treatment of rosacea |
| 03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640003A2 Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist |
| 03/29/2006 | EP1639994A2 Topical composition comprising N-acetylaldosamines or N-acetylamino acids |
| 03/29/2006 | EP1639991A2 Skin and tissue care and/or treatment composition |
| 03/29/2006 | EP1639971A1 Skin protecting compositions |
| 03/29/2006 | EP1638964A1 Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 03/29/2006 | EP1638925A1 Protease inhibitors |
| 03/29/2006 | EP1638582A1 Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas |
| 03/29/2006 | EP1638558A2 Pharmaceutical composition comprising a macrolide immunomodulator |
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638553A1 New use i |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1638543A2 Synergistic combinations of a macrolide t-cell modulator or immunosuppressant and a retinoid |
| 03/29/2006 | EP1638516A2 Barrier formulation comprising a silicone based emulsion |
| 03/29/2006 | EP1501806B1 Preparations for the topical application of anti-androgenically active substances |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 03/29/2006 | EP1409539B1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 03/29/2006 | EP1385496A4 Use of compositions for treating rosacea |
| 03/29/2006 | EP1347765B1 Dermatological aqueous formulations containing clindamycin and a water soluble zinc salt |
| 03/29/2006 | EP1331934B1 Ppar-alpha,beta activators for treating alopecia areata and vitiligo |
| 03/29/2006 | EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/29/2006 | EP1265483B1 Use of phenylethylamine derivatives for the anitmicrobial treatment of surfaces |
| 03/29/2006 | EP1214048B1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/29/2006 | EP1210132A4 Herb medicine composition to be contained in sanitary materials for infants |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | EP0957887B1 Use of composition and a cosmetic method for reducing or preventing stinging. |
| 03/29/2006 | EP0793489B1 Use of statin for the treatment of skin disorders |